Reimbursement & Market Access

Coverage, coding and payment, worked out early enough to shape the clinical trial and the launch.

What we do

Our work includes

The appropriate pathway depends on the product, indication, site of care, provider, payer and available evidence. FDA clearance or approval does not, by itself, establish coverage or payment.

  1. CPT and HCPCS coding strategy
  2. Medicare coverage and payment analysis
  3. Inpatient, outpatient, ambulatory surgery center and physician payment considerations
  4. Clinical trial coverage analysis and billing grids
  5. New technology payment pathway assessment
  6. Hospital economics, value analysis and payer evidence
  7. Field reimbursement support
Deliverables

Typical deliverables

  • Coding, coverage and payment assessment
  • Site-of-care payment model
  • Clinical trial coverage analysis and billing grid
  • New technology payment eligibility assessment
  • Value analysis dossier and payer evidence plan
  • Field reimbursement support plan
Across the product lifecycle

From development to launch and growth

  1. DevelopmentCoding, coverage and payment landscape; payer evidence requirements.
  2. Pivotal trialClinical trial coverage analysis, billing grids and economic endpoints.
  3. Market entryCoding strategy, new-technology payment assessment and payer engagement planning.
  4. Launch and growthField reimbursement support, value analysis and coverage expansion.

Discuss reimbursement and market access.